Elena López-Miranda - 9Medical Oncology, Hospital Universitario Ramon y Cajal

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 71 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract PO3-05-07: SOLTI-1718 NEREA Trial: Neratinib in Hormone Receptor (Hr)-Positive/her2-negative HER2-enriched (HER2-E) Advanced Breast Cancer (BC)

Eva Ciruelos,Cristina Saura,Xavier Gonzalez-Farré,Francisco Javier Salvador Bofill,Maria Vidal,Isabel Blancas,Elena López-Miranda,Maria Iglesias,Míriam Arumí,Mireia Margelí,Catarina Pulido, Serafin Morales Murillo,Fernando Henao, Pilar Sanchez,Sara Alves, Ana Godoy Ortiz,José Passos Coelho,Santiago Escrivá-de-Romaní,Alejandra Espinosa,Tomás Pascual,Aleix Prat

Cancer Researchno. 9_Supplement (2024): PO3-05

Cited0Views0Bibtex

992 Impact of molecular status on chemotherapy response score (CRS) in advanced epithelial ovarian cancer (AEOC)

Elena Vida Navas, Patricia Pérez De Aguado Rodríguez, Javier Pozas Pérez, Eva Guerra Alia, Belén Pérez Míes,Cristina Saavedra Serrano,María Gion Cortés,María Fernández Abad,Noelia Martínez Jáñez, Verónica Barca Tierno,Elena López Miranda,Alfonso Cortés Salgado

Poster and E-Posters (2024)

Cited0Views0Bibtex

LBA23 ABIGAIL: Randomized Phase II Study of Abemaciclib Plus Endocrine Therapy (ET) with or Without a Short Course of Induction Paclitaxel in Patients (pts) with Previously Untreated HR-positive/HER2-negative Advanced Breast Cancer (HR+/HER2- ABC) with Aggressive Disease Criteria

J. de la Haba Rodriguez, J. Cortés,S. Di Cosimo,I. Blancas López-Barajas,S.P. Cortez Castedo, A. López,E. López-Miranda, H. Pla Juher,C.R. Albacar Miro, J. Ponce,V. Carañana Ballerini, L. Paris Bouzas,M. Valero Arbizu, M.R.B. Ruiz Borrego,V. Iranzo, A. Garrido, D. Alcalá-López,L. Mina,J.J. Garcia Mosquera,A. Llombart Cussac

Annals of Oncology (2024)

Cited0Views0Bibtex

Ipatasertib (IPA) Combined with Non-Taxane Chemotherapy (CT) for Patients (pts) with Previously Treated Advanced Triple-Negative Breast Cancer (atnbc): the PATHFINDER Phase IIa Trial

Elena Lopez-Miranda,Jose Manuel Perez Garcia,Maria Gion,Nuria Ribelles,Patricia Cortez,Jose Luis Alonso Romero,Maria Martinez-Garcia,Santiago Gonzalez-Santiago,Begona Bermejo,Serafin Morales Murillo,Vicente Caranana,Laia Garrigos, Melissa Fernandez, Olga Boix,Daniel Alcala-Lopez,Javier Cortes,Antonio Llombart

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

Cited0Views0Bibtex

65P Chemotherapy Response Score (CRS) and Efficacy of PARP Inhibitor (parpi) Treatment in Advanced Epithelial Ovarian Cancer (AEOC)

P. Pérez de Aguado, E.M. Vida Navas,F. Longo Muñoz, E.M. Guerra Alia,M. Gion Cortes,M. Fernandez Abad,C. Saavedra Serrano, N. Martinez,E. López-Miranda, V. Barca-Tierno,B. Pérez Míes, P. Sotoca-Rubio, A.M. Barrill Corpa,V. Alia Navarro, J. Moreno, J.C. Calvo,A. Cortes Salgado

ESMO Open (2024)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn